文献速递临床试验与 GCP流行病学与生物统计

针刺与克罗米芬治疗中国多囊卵巢综合征女性的随机临床试验

Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01

该双盲(克罗米芬对比安慰剂)、单盲(活性针刺对比对照针刺)析因试验在中国大陆21个中心(27家医院)纳入1000例多囊卵巢综合征女性,评估活性针刺单用或联合克罗米芬能否提高活产率。结果显示克罗米芬组活产率显著高于安慰剂组(28.7% vs 15.4%),活性针刺组与对照针刺组活产率无显著差异(21.8% vs 22.4%),针刺未增加活产。

要点

  • 克罗米芬组活产率28.7%,安慰剂组15.4%,差异13.3%(95%CI 8.0%~18.5%)。
  • 活性针刺组活产率21.8%,对照针刺组22.4%,差异-0.6%(95%CI -5.9%~4.7%)。
  • 活性针刺组腹泻和瘀斑发生率高于对照针刺组。

核心结论

  • 在中国多囊卵巢综合征女性中,与对照针刺和安慰剂相比,针刺联合或不联合克罗米芬均未增加活产。
  • 该发现不支持将针刺作为此类女性的不孕治疗方法。

研究设计与样本

  • 双盲(克罗米芬对比安慰剂)、单盲(活性针刺对比对照针刺)析因试验。
  • 2012年7月6日至2014年11月18日在中国大陆21个中心(27家医院)开展,妊娠随访10个月至2015年10月7日。
  • 1000例中国多囊卵巢综合征女性按1:1:1:1随机分为4组,每组250例;926例(92.6%)完成试验。
  • 平均(SD)年龄27.9(3.3)岁,平均(SD)体重指数24.2(4.3)。

主要发现

  • 活性针刺联合克罗米芬组活产69/235例(29.4%),对照针刺联合克罗米芬组66/236例(28.0%)。
  • 活性针刺联合安慰剂组活产31/223例(13.9%),对照针刺联合安慰剂组39/232例(16.8%)。
  • 活性针刺与克罗米芬无显著交互作用(P=0.39)。
  • 克罗米芬组活产率显著高于安慰剂组(135/471例[28.7%] vs 70/455例[15.4%],差异13.3%,95%CI 8.0%~18.5%)。
  • 活性针刺组与对照针刺组活产率无显著差异(100/458例[21.8%] vs 105/468例[22.4%],差异-0.6%,95%CI -5.9%~4.7%)。

关键数值与推荐

  • 主要结局为活产。
  • 次要结局包括不良事件。
  • 活性针刺为深刺合并手动与低频电刺激,每周2次、每次30分钟;对照针刺为浅刺、无手动刺激和模拟电刺激。
  • 克罗米芬或安慰剂每周期给药5天,最多4个周期。

临床怎么用

  • 原文结论为针刺联合或不联合克罗米芬未增加活产,不支持将针刺作为此类女性的不孕治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Acupuncture is used to induce ovulation in some women with polycystic ovary syndrome, without supporting clinical evidence. OBJECTIVE: To assess whether active acupuncture, either alone or combined with clomiphene, increases the likelihood of live births among women with polycystic ovary syndrome. DESIGN, SETTING, AND PARTICIPANTS: A double-blind (clomiphene vs placebo), single-blind (active vs control acupuncture) factorial trial was conducted at 21 sites (27 hospitals) in mainland China between July 6, 2012, and November 18, 2014, with 10 months of pregnancy follow-up until October 7, 2015. Chinese women with polycystic ovary syndrome were randomized in a 1:1:1:1 ratio to 4 groups. INTERVENTIONS: Active or control acupuncture administered twice a week for 30 minutes per treatment and clomiphene or placebo administered for 5 days per cycle, for up to 4 cycles. The active acupuncture group received deep needle insertion with combined manual and low-frequency electrical stimulation; the control acupuncture group received superficial needle insertion, no manual stimulation, and mock electricity. MAIN OUTCOMES AND MEASURES: The primary outcome was live birth. Secondary outcomes included adverse events. RESULTS: Among the 1000 randomized women (mean [SD] age, 27.9 [3.3] years; mean [SD] body mass index, 24.2 [4.3]), 250 were randomized to each group; a total of 926 women (92.6%) completed the trial. Live births occurred in 69 of 235 women (29.4%) in the active acupuncture plus clomiphene group, 66 of 236 (28.0%) in the control acupuncture plus clomiphene group, 31 of 223 (13.9%) in the active acupuncture plus placebo group, and 39 of 232 (16.8%) in the control acupuncture plus placebo group. There was no significant interaction between active acupuncture and clomiphene (P = .39), so main effects were evaluated. The live birth rate was significantly higher in the women treated with clomiphene than with placebo (135 of 471 [28.7%] vs 70 of 455 [15.4%], respectively; difference, 13.3%; 95% CI, 8.0% to 18.5%) and not significantly different between women treated with active vs control acupuncture (100 of 458 [21.8%] vs 105 of 468 [22.4%], respectively; difference, -0.6%; 95% CI, -5.9% to 4.7%). Diarrhea and bruising were more common in patients receiving active acupuncture than control acupuncture (diarrhea: 25 of 500 [5.0%] vs 8 of 500 [1.6%], respectively; difference, 3.4%; 95% CI, 1.2% to 5.6%; bruising: 37 of 500 [7.4%] vs 9 of 500 [1.8%], respectively; difference, 5.6%; 95% CI, 3.0% to 8.2%). CONCLUSIONS AND RELEVANCE: Among Chinese women with polycystic ovary syndrome, the use of acupuncture with or without clomiphene, compared with control acupuncture and placebo, did not increase live births. This finding does not support acupuncture as an infertility treatment in such women. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01573858.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Wu XK, Stener-Victorin E, Kuang HY, et al. Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial. JAMA. 2017. PMID: 28655015. doi:10.1001/jama.2017.7217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。